INTEGRA LIFESCIENCES HOLDINGS CORP Acquisitions, Net of Cash Acquired
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Acquisitions, Net of Cash Acquired of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-10-30
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for the quarter ending 2017-12-31 was $1.02B.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for fiscal 2019 was $30.51M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for fiscal 2018 was -$26.70M, a 102.15% decline from fiscal 2017.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for fiscal 2017 was $1.24B.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire businesses, net of cash acquired for fiscal 2016 was -$225.00K, a 100.07% decline from fiscal 2015.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $281.99M 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | $281.99M 10-Q · filed 2025-07-31 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-07-29 | |||
| 2019-12-31 | $30.51M 10-K · filed 2020-02-21 | |||
| 2018-12-31 | -$26.70M 10-K · filed 2020-02-21 | |||
| 2017-12-31 | $1.02B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $1.02B derived: sum of 2 quarters · filed 2020-02-21 | $1.05B derived: sum of 3 quarters · filed 2020-02-21 | $1.24B 10-K · filed 2020-02-21 |
| 2017-09-30 | -$192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $31.62M derived: sum of 2 quarters · filed 2017-10-26 | $225.55M 10-Q · filed 2017-10-26 | $225.33M derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-06-30 | $31.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $225.74M 10-Q · filed 2017-07-26 | $225.52M derived: sum of 3 quarters · filed 2018-03-01 | $225.52M derived: sum of 4 quarters · filed 2018-03-01 |
| 2017-03-31 | $193.93M 10-Q · filed 2017-04-26 | $193.70M derived: sum of 2 quarters · filed 2018-03-01 | $193.70M derived: sum of 3 quarters · filed 2018-03-01 | $193.70M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$225.00K derived: sum of 2 quarters · filed 2018-03-01 | -$225.00K derived: sum of 3 quarters · filed 2018-03-01 | -$225.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 derived: sum of 2 quarters · filed 2017-10-26 | $0.00 10-Q · filed 2017-10-26 | $20.63M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $0.00 10-Q · filed 2017-07-26 | $20.63M derived: sum of 3 quarters · filed 2018-03-01 | $328.89M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-26 | $20.63M derived: sum of 2 quarters · filed 2018-03-01 | $328.89M derived: sum of 3 quarters · filed 2018-03-01 | $328.89M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $20.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $328.89M derived: sum of 2 quarters · filed 2018-03-01 | $328.89M derived: sum of 3 quarters · filed 2018-03-01 | $328.89M 10-K · filed 2018-03-01 |
| 2015-09-30 | $308.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $308.26M derived: sum of 2 quarters · filed 2016-10-28 | $308.26M 10-Q · filed 2016-10-28 | $394.18M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $0.00 10-Q · filed 2015-07-31 | $85.92M derived: sum of 3 quarters · filed 2017-02-23 | $85.92M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 | $85.92M derived: sum of 2 quarters · filed 2017-02-23 | $85.92M derived: sum of 3 quarters · filed 2017-02-23 | $85.92M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $85.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $85.92M derived: sum of 2 quarters · filed 2017-02-23 | $85.92M derived: sum of 3 quarters · filed 2017-02-23 | $320.92M 10-K · filed 2017-02-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $235.00M 10-Q · filed 2015-11-04 | $235.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $235.00M 10-Q · filed 2015-07-31 | $235.00M derived: sum of 3 quarters · filed 2016-02-26 | $235.15M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $235.00M 10-Q · filed 2015-05-01 | $235.00M derived: sum of 2 quarters · filed 2016-02-26 | $235.15M derived: sum of 3 quarters · filed 2016-02-26 | $235.21M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $150.00K derived: sum of 2 quarters · filed 2016-02-26 | $214.00K derived: sum of 3 quarters · filed 2016-02-26 | $2.98M 10-K · filed 2016-02-26 |
| 2013-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $214.00K derived: sum of 2 quarters · filed 2014-11-07 | $2.98M 10-Q · filed 2014-11-07 | $8.08M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $2.83M 10-Q · filed 2014-08-05 | $7.93M derived: sum of 3 quarters · filed 2015-02-27 | $7.24M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $2.77M 10-Q · filed 2014-05-01 | $7.87M derived: sum of 2 quarters · filed 2015-02-27 | $7.18M derived: sum of 3 quarters · filed 2015-02-27 | $9.87M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.41M derived: sum of 2 quarters · filed 2015-02-27 | $7.10M derived: sum of 3 quarters · filed 2015-02-27 | $7.28M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$690.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $2.00M derived: sum of 2 quarters · filed 2013-10-30 | $2.18M 10-Q · filed 2013-10-30 | $4.71M derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-06-30 | $2.69M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $2.87M 10-Q/A · filed 2013-08-02 | $5.40M derived: sum of 3 quarters · filed 2014-06-20 | $74.02M derived: sum of 4 quarters · filed 2014-06-20 |
| 2012-03-31 | $175.00K 10-Q · filed 2013-05-02 | $2.71M derived: sum of 2 quarters · filed 2014-06-20 | $71.33M derived: sum of 3 quarters · filed 2014-06-20 | |
| 2011-12-31 | $2.53M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $71.15M derived: sum of 2 quarters · filed 2014-06-20 | $151.95M 8-K · filed 2014-06-20 | |
| 2011-09-30 | $68.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $149.42M 10-Q · filed 2012-10-24 | ||
| 2011-06-30 | $80.80M 10-Q · filed 2012-07-31 | |||
| 2010-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.76M derived: sum of 2 quarters · filed 2013-02-26 | $5.18M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $4.17M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | $2.42M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $56.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $56.64M derived: sum of 2 quarters · filed 2012-02-27 | $60.78M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $4.79M 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | $4.14M 10-Q · filed 2010-07-29 | |||
| 2008-12-31 | $86.87M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |